Company Overview and News
The utility is often mentioned favorably due to positive economic and population trends; however, these trends hide declining electricity sales.
I am a value investor. I favor value stocks and stay away from big momentum plays, the growth stocks that are delivering crazy returns, and stocks that have been overvalued for longer than I care to remember. While that often results in missing out on incredible runs in some stocks, such as Netflix, Inc. (NASDAQ: NFLX) and Tesla Inc. (NASDAQ: TSLA), my risk appetite is such that I don’t want to get caught holding the bag.
With nothing more than a quick glance at the headlines, one might conclude it’s just another case of the analyst community playing a game of “chicken,” with NVIDIA Corporation (NASDAQ:NVDA) serving as the proverbial guinea pig. The game? Who’s willing to set the highest target price for NVDA stock.
Millenial wealth can be a sensitive subject. Last week, MarketWatch tweeted out an article offering readers some retirement advice.
With Tesla being so crowded on the short side, things are quite risky for shorts right now.
Tesla (NASDAQ: TSLA) dropped the prices of its cars sold in China after the nation cut some auto import tariffs. According to Reuters:
Fundamental metrics are pointing in the right direction with valuation multiples showing that MU is not expensive.
Oil hit multi-year highs and stocks chopped slightly lower on Tuesday. In other words, we didn’t get too much action on a broad scale. However, that doesn’t mean we didn’t get big moves in individual stocks. With that in mind, let’s look our top stock trades for Wednesday.
Based on 13F filings, I examined Tesla’s institutional investors' sentiment in terms of their holdings in Tesla shares.
U.S. stock futures are surging higher this morning. Wall Street bulls are taking charge again after the U.S. and China called a trade truce that could lower America’s Chinese trade deficit.
In this article I explain my investing strategy and provide 100% access to my real-money portfolio.
Elon Musk said in a series of tweets that Tesla Inc. (NASDAQ: TSLA) will launch a new, powerful and feature-packed version of its new Model 3. Among other things, it will have dual engines and is better than a BMW M3 ultra-fast sports car.
As usual, Tesla (NASDAQ: TSLA) did not issue a press release about its newest product. CEO Elon Musk sent a series of tweets to launch the new dual motor Model 3. The news did not help mask the fact that the company is in trouble. It did speak to Tesla’s ongoing string of innovations
Last April, I pondered whether Ford Motor Company (NYSE:F) could afford to buy Tesla Inc (NASDAQ:TSLA). For the sake of Ford stock, here’s why I think Ford absolutely should buy Tesla.
He’s appeared at a flashy Tesla product unveiling and a thunderous SpaceX launch while his boardroom chairs have sat empty. Now Steve Jurvetson is surfacing as the central figure in the debate over governance at Elon Musk’s Palo Alto car company.
2017-10-09 - Asif
Tesla Motors's mission is to accelerate the world’s transition to sustainable energy. The company design, develop, manufacture, lease and sell high-performance fully electric vehicles, solar energy generation systems and energy storage products. The company also offer maintenance, installation, operation and other services related to its products. Automotive Tesla Motors production vehicle fleet includes Model S premium sedan and Model X sport utility vehicle, which are its highest-performance and most capable vehicles, and beginning in July 2017, its Model 3, a lower priced sedan designed for the mass market. The company continue to enhance its vehicle offerings with enhanced Autopilot options, Internet connectivity and free over-the-air software updates. The company continually deploy its internally developed software into the vehicle fleet, depending on the hardware of the vehicle, to provide additional safety and convenience features. The company are also actively working ...
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET